Last reviewed · How we verify

Atropine sulfate and epinephrine

Dar El Oyoun Hospital · FDA-approved active Small molecule

Atropine sulfate and epinephrine is a Anticholinergic agent and sympathomimetic amine combination Small molecule drug developed by Dar El Oyoun Hospital. It is currently FDA-approved for Organophosphate or carbamate poisoning, Anaphylaxis, Severe bradycardia with hypotension. Also known as: Atropine (Misr.co), Epinephrine (Misr.co).

Atropine blocks muscarinic acetylcholine receptors to reduce parasympathetic effects, while epinephrine stimulates adrenergic receptors to increase heart rate and blood pressure.

Atropine blocks muscarinic acetylcholine receptors to reduce parasympathetic effects, while epinephrine stimulates adrenergic receptors to increase heart rate and blood pressure. Used for Organophosphate or carbamate poisoning, Anaphylaxis, Severe bradycardia with hypotension.

At a glance

Generic nameAtropine sulfate and epinephrine
Also known asAtropine (Misr.co), Epinephrine (Misr.co)
SponsorDar El Oyoun Hospital
Drug classAnticholinergic agent and sympathomimetic amine combination
TargetMuscarinic acetylcholine receptors (atropine); alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors (epinephrine)
ModalitySmall molecule
Therapeutic areaEmergency Medicine / Toxicology
PhaseFDA-approved

Mechanism of action

Atropine sulfate is an anticholinergic agent that antagonizes muscarinic receptors, reducing salivation, bronchial secretions, and vagal effects on the heart. Epinephrine is a sympathomimetic amine that activates alpha and beta adrenergic receptors, increasing cardiac output, blood pressure, and bronchial dilation. This combination is used in emergency settings to counteract severe parasympathomimetic poisoning or anaphylaxis.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Atropine sulfate and epinephrine

What is Atropine sulfate and epinephrine?

Atropine sulfate and epinephrine is a Anticholinergic agent and sympathomimetic amine combination drug developed by Dar El Oyoun Hospital, indicated for Organophosphate or carbamate poisoning, Anaphylaxis, Severe bradycardia with hypotension.

How does Atropine sulfate and epinephrine work?

Atropine blocks muscarinic acetylcholine receptors to reduce parasympathetic effects, while epinephrine stimulates adrenergic receptors to increase heart rate and blood pressure.

What is Atropine sulfate and epinephrine used for?

Atropine sulfate and epinephrine is indicated for Organophosphate or carbamate poisoning, Anaphylaxis, Severe bradycardia with hypotension.

Who makes Atropine sulfate and epinephrine?

Atropine sulfate and epinephrine is developed and marketed by Dar El Oyoun Hospital (see full Dar El Oyoun Hospital pipeline at /company/dar-el-oyoun-hospital).

Is Atropine sulfate and epinephrine also known as anything else?

Atropine sulfate and epinephrine is also known as Atropine (Misr.co), Epinephrine (Misr.co).

What drug class is Atropine sulfate and epinephrine in?

Atropine sulfate and epinephrine belongs to the Anticholinergic agent and sympathomimetic amine combination class. See all Anticholinergic agent and sympathomimetic amine combination drugs at /class/anticholinergic-agent-and-sympathomimetic-amine-combination.

What development phase is Atropine sulfate and epinephrine in?

Atropine sulfate and epinephrine is FDA-approved (marketed).

What are the side effects of Atropine sulfate and epinephrine?

Common side effects of Atropine sulfate and epinephrine include Tachycardia, Hypertension, Tremor, Anxiety, Dry mouth, Mydriasis (dilated pupils).

What does Atropine sulfate and epinephrine target?

Atropine sulfate and epinephrine targets Muscarinic acetylcholine receptors (atropine); alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors (epinephrine) and is a Anticholinergic agent and sympathomimetic amine combination.

Related